Wegovy, also known as semaglutide, is a once-weekly injectable medication approved by the FDA for the treatment of obesity and overweight-related comorbidities such as type 2 diabetes. It works by mimicking the effects of the hormone GLP-1, which regulates appetite and glucose metabolism, helping individuals to lose weight and improve their blood sugar control. It is only available by prescription and has shown to be effective in clinical trials.
Ashish Tripathi, founder and CEO of Tzar Labs, as well as chairman of Epigeneres Biotech, the Indian firm where the test was first developed in 2021, has published a study this month in the journal Stem Cells, saying that they have found a breakthrough 'holy grail' of cancer detection that predicts tumors a year before they form.
The NIH has restarted the 'Bat Virus Grant' to Peter Daszak and EcoHealth Alliance, a nonprofit research organization in New York City, which is a new 4-year grant that represents a stripped-down version of the original grant.
The American Medical Association, the largest organization of doctors in the US, stated that the metric Body Mass Index is now considered racist. A leading US medical organization is urging doctors to ditch body...
Tokyo-based Meiji Seika Pharma has received approval in Japan to produce the world’s first self-amplifying mRNA COVID-19 vaccine without safety data. The world's first COVID-19 self-amplifying mRNA (sa-mRNA) vaccine...
An environmental scientist Al Lupiano, found the answer to a medical mystery which links him and 100 other people who have been diagnosed with rare cancers and went to the same New Jersey high school.
A study has found a new way to regenerate insulin-producing cells to treat diabetes in the form of MNK2 protein. The MNK2 protein could serve as a source of insulin for both type 1 and type 2 diabetes.
According to results released by WHO Director-General Tedros Adhanom Ghebreyesus, the deaths of children in Gambia have been linked to cough syrups made in India.
Billionaire Mukesh Ambani’s group is getting into genetic mapping, looking to make a health care trend led by disruptive US startups like 23andMe more affordable and widespread in India’s growing consumer market.
According to Dr. Kaori Sakurada from Yamagata University, men with higher libido are 69% less likely to die young than their peers.